Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

The objective was to evaluate the prognostic impact of pre-transplant minimal residual disease (MRD) as determined by real-time quantitative polymerase chain reaction in 67 adult NPM1-mutated acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). Twenty-...

Full description

Bibliographic Details
Main Authors: Kayser, S, Benner, A, Thiede, C, Martens, U, Huber, J, Stadtherr, P, Janssen, J W G, Röllig, C, Uppenkamp, M J, Bochtler, T, Hegenbart, U, Ehninger, G, Ho, A D, Dreger, P, Krämer, A
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030374/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030374/

Similar Items